Several CNS Indications Position Transdermal Drugs for Growth

(Nashua NH) – Despite recent progress in a number of therapeutic sectors, progress toward curative medicine for neurological and related central nervous system disorders has remained elusive. The result is a therapeutic sector that relies heavily on control of symptoms and palliative care. This disappointing picture is being exacerbated by disease trends that are increasing the morbidity and mortality associated with CNS ailments in the general population. These trends include the growing incidence of neurological disorders associated with longevity and aging, and significant increases in the number of children diagnosed with autism.

Because diseases of the central nervous system often result in compromised cognitive and/or motor skills that can increase the level of involuntary non-compliance with therapeutic protocols, transdermal delivery of drugs targeting CNS disorders is generally viewed as an approach that can increase patient safety and improve outcomes. In addition to the handful of FDA-approved transdermal CNS products, more than a dozen companies are currently pursuing a range of APIs in transdermal delivery systems that target neurological and CNS conditions. While none of these development-stage candidates is curative, the benefits they can offer in terms of patient ease-of-use, product safety and overall quality-of-care are expected to result in reduced morbidity and more effective symptom management for afflicted patients.

Applied Data’s analysis of the global transdermal CNS segment includes an assessment of factors influencing demand for transdermal CNS drug products, the key players in this segment, the regulatory and industry environment, and the dynamics of patient care that will affect market development. Product assessments, market segment analysis and competitor profiles complement the text.

More information is available at www.applieddata.org .

Source: Applied Data Research

About Applied Data Research

Applied Data Research is a management consulting firm, assisting decision makers by providing comprehensive publications designed to reveal key relationships, patterns and trends affecting their businesses. These information tools contain comprehensive, timely, and insightful analysis and assessments, allowing users to make informed tactical and strategic decisions.

Contact:

Greg Stone
Applied Data Research
98 Amherst Street
Amherst, NH 03031 USA
Voice: 603-718-4564
www.applieddata.org

This release was published on openPR.